FDA Announces Vaccines and Related Biological Products Advisory Committee Meeting

Summary

The Food and Drug Administration (FDA) is hosting a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to provide advice on FDA's regulatory issues, following a delay by the World Health Organization (WHO) in recommending an H3N2 strain for seasonal influenza vaccines.